Literature DB >> 9830444

[Mono- versus polychemotherapy in advanced non-small cell bronchial carcinoma].

M Baumann, C Petersen.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9830444     DOI： 10.1007/bf03038300

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  5 in total

1.  Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.

Authors: 
Journal:  J Clin Oncol       Date:  1997-08       Impact factor: 44.544

2.  Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party.

Authors:  F R Macbeth; J J Bolger; P Hopwood; N M Bleehen; J Cartmell; D J Girling; D Machin; R J Stephens; A J Bailey
Journal:  Clin Oncol (R Coll Radiol)       Date:  1996       Impact factor: 4.126

3.  Single-agent chemotherapy versus combination chemotherapy in advanced non-small cell lung cancer: a quality and meta-analysis study.

Authors:  P Marino; A Preatoni; A Cantoni; G Buccheri
Journal:  Lung Cancer       Date:  1995-08       Impact factor: 5.705

4.  Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: a meta-analysis of response, toxicity, and survival.

Authors:  R C Lilenbaum; P Langenberg; K Dickersin
Journal:  Cancer       Date:  1998-01-01       Impact factor: 6.860

5.  Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group.

Authors: 
Journal:  BMJ       Date:  1995-10-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.